Global Leishmaniasis Treatment Market

Posted by kalpesh rajput on April 20th, 2021

Global Leishmaniasis Treatment Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 8.5% during a forecast period. Global Leishmaniasis Treatment Market Overview: Leishmaniasis is one of the neglected tropical diseases caused by different species of the protozoan parasite Leishmania. It is spread by the bite of certain types of sandflies and occurs most frequently in the tropics and sub-tropics of Africa, Asia, the Americas, and southern Europe. The disease can present in three main ways: cutaneous, mucosal, and visceral. Global Leishmaniasis Treatment Market Dynamics: Lack of hygiene and poor sanitation facilities in some rural areas are the main causes for the spread of Leishmaniasis and drives the market growth. Factors like the high prevalence of target diseases in some underdeveloped and developing nations, prevalence of malnutrition across the globe and migratory patterns of a population boost the demand for the Leishmaniasis Treatment market. According to the data of 2017, the World Health Organization (WHO) has stated that Leishmaniasis is one of the most neglected diseases, with 350 million people considered at risk of contracting the disease, with a burden of about 12 million people currently infected in 98 countries, and two million new cases estimated to occur annually. Besides this, an increase in R & D funding, introduction of new chemical entities, favourable government initiatives, and new development in the therapy area also create potential growth opportunities for the market growth. However, lack of awareness in some developing countries and long duration for treatment may hamper the market growth. The report has profiled Seventeen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region. Global Leishmaniasis Treatment Market Segment Analysis: The Global Leishmaniasis Treatment Market is segmented on the basis of Type, Pathological Tests, Drug Type and End-Users. Based on Type, Cutaneous Leishmaniasis is expected to hold a dominant market share during the forecast period. This is the most common form of leishmaniasis, both in general and in U.S. travellers. Cutaneous Leishmaniasis causes skin lesions, which can persist for months, sometimes years. About 1.5 million new cases of cutaneous leishmaniasis and 500 000 new cases of visceral leishmaniasis occur each year around the world. Based on Pathological Tests, Serological Tests held a dominant share of XX% in 2019. The segment is expected to grow due to the surge in demand for pathological testing for the diagnosis of various infectious diseases. Leishmaniasis is also linked to environmental changes such as deforestation, the building of dams, irrigation schemes, and urbanization. Recent Developments: • According to the news released in March 2020, Novartis and the Drugs for Neglected Diseases initiative signed a collaboration and license agreement to jointly develop LXE408, as a potential new oral treatment for visceral leishmaniasis, one of the world's leading parasitic killers. • Gilead science signed an agreement with WHO in 2016, to donate 445,000 vials of AmBisome to the World Health Organization for the tenure of 5 years which is a leading brand being used for the treatment of leishmaniasis. Global Leishmaniasis Treatment Market To know about the Research Methodology :- Request Free Sample Report Global Leishmaniasis Treatment Market Regional Insights: Global Leishmaniasis Treatment Market Regional Insights North America held a dominant market share in 2019. The region is expected to continue the dominance throughout the forecast period. The region is experiencing lucrative growth owing to factors such as the prevalence of sedentary and unhealthy lifestyle, a high number of target diseases, rise in FDA approval for products, ongoing clinical trials and presence of favourable government policies. These factors create the potential for market growth in the region. The report also helps in understanding the Global Leishmaniasis Treatment Market dynamics, structure by analyzing the market segments and project the Global Leishmaniasis Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Leishmaniasis Treatment Market make the report investor’s guide. Global Leishmaniasis Treatment Market Scope: Inquire before buying Global Leishmaniasis Treatment Market Global Leishmaniasis Treatment Market, by Region: • North America • Europe • South America • MEA • APAC Global Leishmaniasis Treatment Market Key Players • Sequus Pharmaceuticals Inc. • Novartis • Gland Pharma Limited • Paladin Labs Inc. • Sanofi S.A. • Gilead Life sciences • Lifecare Innovations Private Limited • Enzon Pharmaceuticals Inc. • Profounda, Inc. • Merck • iCo Therapeutics • AEterna Zentaris • Eurofins Advinus • Pieris Pharmaceuticals • GloxoSmithKline • Pfizer • Jassen Pharmaceutical This report submitted by Maximize market Research Company Customization of the report: Maximize MarketResearch provides free personalized of reports as per your demand.This reportcan be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908